Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,231.85
+11.10 (0.91%)
At close: Oct 16, 2026
Dr. Reddy's Laboratories Stock Forecast
Stock Price Forecast
According to 37 analysts polled by S&P Global, Dr. Reddy's Laboratories stock has a consensus rating of "Hold" and an average price target of ₹1,284. The average 1-year stock price forecast is 4.21% higher than the current stock price, while the lowest is ₹1,039 (-15.66%) and the highest is ₹1,740 (+41.25%).
Price Target: ₹1,284 (+4.21%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Dr. Reddy's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 11 | 11 | 13 | 14 |
| Buy | 5 | 5 | 4 | 4 | 3 | 4 |
| Hold | 10 | 10 | 11 | 11 | 10 | 7 |
| Sell | 6 | 6 | 8 | 8 | 8 | 8 |
| Strong Sell | 6 | 6 | 6 | 5 | 4 | 4 |
| Total | 39 | 39 | 40 | 39 | 38 | 37 |
Financial Forecast
Revenue This Year
351.92B
from 335.93B
Increased by 4.76%
Revenue Next Year
393.11B
from 351.92B
Increased by 11.70%
EPS This Year
43.91
from 55.39
Decreased by -20.72%
EPS Next Year
58.81
from 43.91
Increased by 33.93%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.